Literature DB >> 10647605

Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease.

J W Ashford1, W J Shih, J Coupal, R Shetty, A Schneider, C Cool, A Aleem, V H Kiefer, M S Mendiondo, F A Schmitt.   

Abstract

UNLABELLED: To determine the relationship between cerebral cortical blood flow loss and the temporal development of the dementia in Alzheimer's disease (AD), SPECT was studied in a cross section of AD patients with a broad range of impairment.
METHODS: Thirty patients with a diagnosis of probable AD had their mini-mental state examination scores transformed into time-index values to give an estimation of dementia severity relative to the developmental time course. SPECT images were obtained using 99mTc-ethyl cysteinate dimer and a 3-head camera. Cortical surface perfusion was analyzed, including modified Talairach standardization, to obtain cortical elements from the convexity (each representing about 0.25 cm2 at the surface, 6.6-mm cortical depth) referenced to the mean perfusion of the full greater cerebellar hemisphere. These element ratios were analyzed (individually and by averages of estimated Brodmann's areas and brain regions) using linear regression with the time-index value.
RESULTS: For individual posterotemporal and inferoparietal Brodmann's areas (21, 22 and 39, 40, respectively) the correlation coefficients between cortical perfusion ratios and dementia severity ranged between -0.67 and -0.78 (P < 0.001). Perfusion ratios from these regions declined 2.5%-4.2% for each estimated year of progression. Prefrontal area perfusion showed less association with severity. Perfusion in primary cortical regions had no significant association with dementia severity.
CONCLUSION: Cerebral cortical perfusion loss is temporally related to development of dementia. The spatial pattern of high, significant correlations between cortical perfusion and dementia severity shows a regional distribution that corresponds closely to the distribution of AD pathology described in autopsy studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10647605

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

1.  A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Georgina Vinyes-Junqué; Ana Espinosa; Sergi Valero; Isabel Hernández; Isabel Roca; Agustín Ruíz; Maitée Rosende-Roca; Ana Mauleón; James T Becker; Joan Castell-Conesa; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Ana Espinosa; Sergi Valero; Isabel Hernández; Agustín Ruíz; James T Becker; Maitée Rosende-Roca; Ana Mauleón; Oscar Sotolongo; Joan Castell-Conesa; Isabel Roca; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Initial mini-mental state and cerebral perfusion in Alzheimer's disease.

Authors:  T Ones; I Midi; F Dede; N Tuncer; T Y Erdil; O Onultan; S Ceylan; S Inanir; H T Turoglu
Journal:  Clin Neuroradiol       Date:  2012-01-03       Impact factor: 3.649

4.  Imaging the Alzheimer brain.

Authors:  J Wesson Ashford; Ahmad Salehi; Ansgar Furst; Peter Bayley; Giovanni B Frisoni; Clifford R Jack; Osama Sabri; Maheen M Adamson; Kerry L Coburn; John Olichney; Norbert Schuff; Daniel Spielman; Steven D Edland; Sandra Black; Allyson Rosen; David Kennedy; Michael Weiner; George Perry
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Georgina Vinyes-Junqué; Mercè Boada; Pablo Martínez-Lage; Gemma Cuberas; Ana Espinosa; Isabel Roca; Isabel Hernández; Sergi Valero; Maitée Rosende-Roca; Ana Mauleón; James T Becker And; Lluís Tárraga
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Confirmation rate of blinded (99m)Tc-SPECT compared to neurochemical dementia biomarkers in CSF in patients with Alzheimer disease.

Authors:  Daniela Schmidt; Rüdiger Zimmermann; Piotr Lewczuk; Gerd Schaller; Umüt Degirmenci; Sebastian Kreil; Jens Wiltfang; Torsten Kuwert; Johannes Kornhuber; Markus Weih
Journal:  J Neural Transm (Vienna)       Date:  2010-08-07       Impact factor: 3.575

Review 7.  Modeling the time-course of Alzheimer dementia.

Authors:  J W Ashford; F A Schmitt
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

8.  Brain perfusion SPECT correlates with CSF biomarkers in Alzheimer's disease.

Authors:  Marie-Odile Habert; Leonardo Cruz de Souza; Foudil Lamari; Nelle Daragon; Serge Desarnaud; Claude Jardel; Bruno Dubois; Marie Sarazin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-10       Impact factor: 9.236

Review 9.  APOE genotype effects on Alzheimer's disease onset and epidemiology.

Authors:  J Wesson Ashford
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 10.  [PET and SPECT investigations in Alzheimer's disease].

Authors:  S Asenbaum
Journal:  Radiologe       Date:  2003-06-25       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.